Celldex Therapeutics, Inc. — Director's Dealing 2006

Aug 16, 2006

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVANT IMMUNOTHERAPEUTICS INC (AVAN)
CIK: 0000744218
Period of Report: 2006-08-16

Reporting Person: RYAN UNA S (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2006-08-16	Common Stock	P	30300	$1.355	Acquired	898713	Direct